Search clinical trials for: ertapenem

Total 76 results

University Medical Center Groningen

Completed

PK/PD of Ertapenem In Patients With TB

PK of Ertapenem in TB Patients

Netherlands
University of Michigan

Completed

Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis

Acute Kidney Failure

United States
Catholic University of the Sacred Heart
Merck Sharp & Dohme LLC

Unknown

Safety of Ertapenem in Beta-lactam Allergic Patients.

Allergy | IgE-Mediated Hypersensitivity

Italy
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048)

Urinary Tract Infection
Hartford Hospital
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion

Healthy

United States
HaEmek Medical Center, Israel

Withdrawn

Penetration of Ertapenem Into Bone

Amputation

Israel
Klinikum Hanover-Siloah Hospital

Unknown

Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis

Acute Disease | Diverticulitis, Colonic

Germany
Prince of Songkla University

Unknown

Ertapenem in Patients With Urosepsis

Patients With Urosepis and Received Ertapenem for Treatment

Thailand
Merck Sharp & Dohme LLC

Completed

To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)

Sepsis
Albany College of Pharmacy and Health Sciences
Merck Sharp & Dohme LLC

Completed

Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis

End Stage Renal Disease | Continuous Ambulatory Peritoneal Dialysis

United States
Merck Sharp & Dohme LLC

Completed

To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052)

Pneumonia | Urinary Tract Infection | Infection
Merck Sharp & Dohme LLC

Completed

A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)

Colorectal Surgery
Merck Sharp & Dohme LLC

Terminated

Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)

Urinary Tract Infections
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055)

Urinary Tract Infection
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)

Complicated Intra-abdominal Infection
Olive View-UCLA Education & Research Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Pilot Trial of Antibiotics Versus Surgery for Treating Acute Appendicitis

Acute Uncomplicated Appendicitis

United States
Henry Ford Health System

Withdrawn

A Single Center, Prospective Clinical Trial of Intravenous Ertapenem in the Treatment of Hurley Stage II or III Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States
University Hospital, Bordeaux

Completed

Pharmacokinetics of Ertapenem in Patients Aged Over 75 (PHACINERTA)

Infections

France
Nantes University Hospital

Completed

Pharmacokinetics Ertapenem Burns

Burn Patients

France
Sihuan Pharmaceutical Holdings Group Ltd.

Completed

A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

Complicated Urinary Tract Infection Including Acute Pyelonephritis

China
Daniel Benjamin

Terminated

Pharmacokinetics and Safety of Ertapenem in the Postpartum Period

Endometritis

United States
A.O. Ospedale Papa Giovanni XXIII

Unknown

Antibiotics Versus Surgery in Acute Appendicitis (ASAA)

Acute Appendicitis Without Peritonitis

Italy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia

Community Acquired Pneumonia

China
William Beaumont Hospitals
Wayne State University

Completed

Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients

End Stage Renal Disease

United States
National University Hospital, Singapore
Merck Sharp & Dohme LLC

Unknown

An Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections.

Urinary Tract Infections

Singapore
Instituto Nacional de Cancer, Brazil

Terminated

Ertapenem Administered Subcutaneously Versus Intravenously

Urinary Tract Infections

Brazil
Assistance Publique - Hôpitaux de Paris
Merck Sharp & Dohme LLC

Completed

Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration (ERTAPRO)

Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection

France
Merck Sharp & Dohme LLC

Completed

Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)

Urinary Tract Infections | Soft Tissue Infections | Bacterial Pneumonia
Todd C. Lee MD MPH FIDSA

Not yet recruiting

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia (CERT)

Staphylococcus Aureus Bacteremia | Staphylococcus Aureus Endocarditis | Staphylococcus Aureus Septicemia | Staphylococcal Sepsis

Canada
Poitiers University Hospital

Completed

Comparison of Ertapenem Distribution in the Muscle of Six Healthy Volunteers and Six Critically Ill Patients by Microdialysis

Healthy

France
Taipei Veterans General Hospital, Taiwan

Recruiting

Antibiotic Prophylaxis in Patients Undergoing GVO (ABX-GV)

Sepsis | Fever | Liver Cirrhoses | Gastric Varix

Taiwan
Phramongkutklao College of Medicine and Hospital

Completed

Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia

Bacteremia | Infection, Bacterial

Thailand
Merck Sharp & Dohme LLC

Completed

An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)

Infections | Pelvic Infections
Universidad del Norte

Unknown

Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae (CAPITIS)

Urinary Tract Infections | Enterobacteriaceae Infections | Clinical Trial | Carbapenem | Klebsiella Pneumoniae Infection | Infection Due to ESBL Bacteria | Escherichia Coli Infection | Drug Resistance, Bacterial

Colombia
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056)

Surgical Site Infection | Infection
National Institute of Allergy and Infectious Diseases...

Completed

Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777)

Bacterial Infection

United States
Chonbuk National University

Completed

Pharmacokinetic Interactions in Combination Treatment of Valproic Acid and Ertapenem in Normal Subjects

Healthy

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)

Foot Infections in Diabetic Patients
Spero Therapeutics

Completed

Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) (ADAPT-PO)

Acute Pyelonephritis | Complicated Urinary Tract Infection

Bulgaria, Georgia, United States, Czechia, Estonia, Hungary, Latvia, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia, Slovakia, South Africa, Ukraine
Silvia M. Pinango L.
Merck Sharp & Dohme LLC

Completed

Early Short-term Antibiotic Therapy in Penetrating Abdominal Trauma, 3 vs 7 Days

SURGICAL SITE INFECTION
Wake Forest University Health Sciences

Completed

Role of Intravenous Versus Home Oral Antibiotics in Perforated Appendicitis

Perforated Appendicitis
Turku University Hospital
Oulu University Hospital; Seinajoki Central Hospital; Tampere University Hospital and other collaborators

Active, not recruiting

Appendicectomy Versus Antibiotics in the Treatment of Acute Uncomplicated Appendicitis (APPAC)

Acute Appendicitis

Finland
Public Health Service of Amsterdam
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Completed

New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea (NABOGO)

Gonorrhea

Netherlands
Assistance Publique Hopitaux De Marseille

Terminated

Prospective, Open-label Study of Pharmacokinetics of Ertapenem in the Muscle Using Microdialysis in Mechanically Ventilated Intensive Care Unit Patients, Treated or Not by Norepinephrine

To Assess the Tissular and Plasma Kinetics of Ertapenem

France
Mahidol University

Unknown

Ertapenem Versus Meropenem/Imipenem for ESBL+ Gram-negative Infections

Drug Safety

Thailand
University of Ulm

Completed

Concentration of Ertapenem in Colorectal Tissue

Rectal Neoplasms | Colonic Neoplasms | Diverticulosis, Colonic

Germany
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia

Community Acquired Pneumonia

China
Spero Therapeutics
CPR Pharma Services Pty Ltd, Australia

Completed

Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994

Healthy Volunteers

Australia
Merck Sharp & Dohme LLC

Completed

Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)

Infection; Diabetic Foot
First Affiliated Hospital Xi'an Jiaotong University
Second Affiliated Hospital of Xi'an Jiaotong University; 3201 Hospital in Hanzhong

Unknown

Clinical Trial Comparing ERAT vs Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis

Acute Appendicitis

China

Search clinical trials for: ertapenem

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations